Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL

Enrollment

1,084

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Nonvalvular Atrial Fibrillation

Interventions

DRUG

AZD0837

ER tablet, PO, once daily for a period of 3-9 months.

DRUG

Vitamin-K antagonist at INR 2-3

Tablet, PO for a period of 3-9 months.

DRUG

AZD0837

ER tablet, PO, twice daily for a period of 3-9 months